Artiva Biotherapeutics (ARTV) Accumulated Depreciation & Amortization: 2023-2025
Historic Accumulated Depreciation & Amortization for Artiva Biotherapeutics (ARTV) over the last 2 years, with Sep 2025 value amounting to $7.8 million.
- Artiva Biotherapeutics' Accumulated Depreciation & Amortization rose 46.63% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year change of. This contributed to the annual value of $5.9 million for FY2024, which is 67.70% up from last year.
- Per Artiva Biotherapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $7.8 million for Q3 2025, which was up 9.02% from $7.2 million recorded in Q2 2025.
- Over the past 5 years, Artiva Biotherapeutics' Accumulated Depreciation & Amortization peaked at $7.8 million during Q3 2025, and registered a low of $3.5 million during Q4 2023.
- Its 3-year average for Accumulated Depreciation & Amortization is $5.9 million, with a median of $5.9 million in 2024.
- Data for Artiva Biotherapeutics' Accumulated Depreciation & Amortization shows a peak YoY spiked of 67.70% (in 2024) over the last 5 years.
- Artiva Biotherapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $3.5 million in 2023, then spiked by 67.70% to $5.9 million in 2024, then surged by 46.63% to $7.8 million in 2025.
- Its last three reported values are $7.8 million in Q3 2025, $7.2 million for Q2 2025, and $6.5 million during Q1 2025.